Biogen Idec | search
Click here to view Biogen Idec news from 60+ newspapers.
Bookmark or Share- Multiple Sclerosis - BiogenAs pioneers in neuroscience, Biogen has an innovative therapeutic pipeline that aims to reverse disability, repair damage, and address other remaining unmet needs in MS, with the goal of significantly altering the course of MS and preventing disease development and disability progression.
- Students & Graduates - BiogenBiogen is developing the next generation of talent in biotech. Hear from students as they discuss their internship experience, what attracted them to Biogen, and how they felt supported by their teams.
- Home | BiogenBiogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity through science while advancing a healthier, more sustainable and equitable world.
- Company | BiogenFounded in 1978, Biogen has pioneered multiple breakthrough innovations including a broad portfolio of medicines to treat multiple sclerosis, the first approved treatment for spinal muscular atrophy, and two co-developed treatments to address a defining pathology of Alzheimer’s disease.
- Careers | BiogenEveryone at Biogen contributes to our mission to create transformative medicines for people who need them the most. Explore our business areas to discover where you can make an impact on our team.
More
